nodes	percent_of_prediction	percent_of_DWPC	metapath
Pasireotide—SSTR2—SIDS Susceptibility Pathways—RYR2—dilated cardiomyopathy	0.0131	0.0142	CbGpPWpGaD
Pasireotide—SSTR5—Peptide GPCRs—CXCR3—dilated cardiomyopathy	0.0126	0.0136	CbGpPWpGaD
Pasireotide—SSTR2—Peptide GPCRs—AGTR2—dilated cardiomyopathy	0.0125	0.0135	CbGpPWpGaD
Pasireotide—SSTR3—Peptide GPCRs—AGTR1—dilated cardiomyopathy	0.0122	0.0132	CbGpPWpGaD
Pasireotide—SSTR5—GPCRs, Class A Rhodopsin-like—MAS1—dilated cardiomyopathy	0.0119	0.0128	CbGpPWpGaD
Pasireotide—SSTR1—Peptide GPCRs—AGTR1—dilated cardiomyopathy	0.0117	0.0127	CbGpPWpGaD
Pasireotide—SSTR2—Peptide GPCRs—CXCR3—dilated cardiomyopathy	0.0116	0.0126	CbGpPWpGaD
Pasireotide—SSTR2—GPCRs, Class A Rhodopsin-like—MAS1—dilated cardiomyopathy	0.011	0.0119	CbGpPWpGaD
Pasireotide—SSTR5—Peptide GPCRs—AGTR1—dilated cardiomyopathy	0.0104	0.0113	CbGpPWpGaD
Pasireotide—SSTR2—GPCRs, Other—CXCR3—dilated cardiomyopathy	0.00984	0.0107	CbGpPWpGaD
Pasireotide—SSTR2—Peptide GPCRs—AGTR1—dilated cardiomyopathy	0.00961	0.0104	CbGpPWpGaD
Pasireotide—SSTR2—GPCRs, Other—ADRB2—dilated cardiomyopathy	0.00772	0.00836	CbGpPWpGaD
Pasireotide—SSTR3—Peptide ligand-binding receptors—CXCL2—dilated cardiomyopathy	0.00749	0.0081	CbGpPWpGaD
Pasireotide—SSTR3—Peptide ligand-binding receptors—AGTR2—dilated cardiomyopathy	0.00749	0.0081	CbGpPWpGaD
Pasireotide—SSTR1—Peptide ligand-binding receptors—AGTR2—dilated cardiomyopathy	0.00718	0.00777	CbGpPWpGaD
Pasireotide—SSTR1—Peptide ligand-binding receptors—CXCL2—dilated cardiomyopathy	0.00718	0.00777	CbGpPWpGaD
Pasireotide—SSTR3—Peptide ligand-binding receptors—CXCR3—dilated cardiomyopathy	0.00696	0.00753	CbGpPWpGaD
Pasireotide—SSTR1—Peptide ligand-binding receptors—CXCR3—dilated cardiomyopathy	0.00667	0.00722	CbGpPWpGaD
Pasireotide—SSTR5—Peptide ligand-binding receptors—CXCL2—dilated cardiomyopathy	0.00637	0.00689	CbGpPWpGaD
Pasireotide—SSTR5—Peptide ligand-binding receptors—AGTR2—dilated cardiomyopathy	0.00637	0.00689	CbGpPWpGaD
Pasireotide—SSTR3—G alpha (i) signalling events—AGTR2—dilated cardiomyopathy	0.00632	0.00683	CbGpPWpGaD
Pasireotide—SSTR3—G alpha (i) signalling events—CXCL2—dilated cardiomyopathy	0.00632	0.00683	CbGpPWpGaD
Pasireotide—SSTR1—SIDS Susceptibility Pathways—GJA1—dilated cardiomyopathy	0.00625	0.00676	CbGpPWpGaD
Pasireotide—SSTR1—G alpha (i) signalling events—CXCL2—dilated cardiomyopathy	0.00606	0.00655	CbGpPWpGaD
Pasireotide—SSTR1—G alpha (i) signalling events—AGTR2—dilated cardiomyopathy	0.00606	0.00655	CbGpPWpGaD
Pasireotide—SSTR5—Peptide ligand-binding receptors—CXCR3—dilated cardiomyopathy	0.00592	0.0064	CbGpPWpGaD
Pasireotide—SSTR2—Peptide ligand-binding receptors—CXCL2—dilated cardiomyopathy	0.00588	0.00636	CbGpPWpGaD
Pasireotide—SSTR2—Peptide ligand-binding receptors—AGTR2—dilated cardiomyopathy	0.00588	0.00636	CbGpPWpGaD
Pasireotide—SSTR3—G alpha (i) signalling events—CXCR3—dilated cardiomyopathy	0.00587	0.00635	CbGpPWpGaD
Pasireotide—SSTR3—GPCRs, Class A Rhodopsin-like—AGTR2—dilated cardiomyopathy	0.00586	0.00634	CbGpPWpGaD
Pasireotide—SSTR3—Peptide ligand-binding receptors—AGTR1—dilated cardiomyopathy	0.00576	0.00623	CbGpPWpGaD
Pasireotide—SSTR1—G alpha (i) signalling events—CXCR3—dilated cardiomyopathy	0.00563	0.00609	CbGpPWpGaD
Pasireotide—SSTR1—GPCRs, Class A Rhodopsin-like—AGTR2—dilated cardiomyopathy	0.00562	0.00608	CbGpPWpGaD
Pasireotide—SSTR1—Peptide ligand-binding receptors—AGTR1—dilated cardiomyopathy	0.00552	0.00597	CbGpPWpGaD
Pasireotide—SSTR2—Peptide ligand-binding receptors—CXCR3—dilated cardiomyopathy	0.00546	0.00591	CbGpPWpGaD
Pasireotide—SSTR3—GPCRs, Class A Rhodopsin-like—CXCR3—dilated cardiomyopathy	0.00545	0.0059	CbGpPWpGaD
Pasireotide—SSTR1—SIDS Susceptibility Pathways—IL10—dilated cardiomyopathy	0.00542	0.00586	CbGpPWpGaD
Pasireotide—SSTR5—G alpha (i) signalling events—CXCL2—dilated cardiomyopathy	0.00537	0.00581	CbGpPWpGaD
Pasireotide—SSTR5—G alpha (i) signalling events—AGTR2—dilated cardiomyopathy	0.00537	0.00581	CbGpPWpGaD
Pasireotide—SSTR3—GPCRs, Class A Rhodopsin-like—ADRB1—dilated cardiomyopathy	0.00528	0.00571	CbGpPWpGaD
Pasireotide—SSTR1—GPCRs, Class A Rhodopsin-like—CXCR3—dilated cardiomyopathy	0.00522	0.00565	CbGpPWpGaD
Pasireotide—SSTR2—SIDS Susceptibility Pathways—GJA1—dilated cardiomyopathy	0.00511	0.00553	CbGpPWpGaD
Pasireotide—SSTR1—GPCRs, Class A Rhodopsin-like—ADRB1—dilated cardiomyopathy	0.00506	0.00547	CbGpPWpGaD
Pasireotide—SSTR3—Class A/1 (Rhodopsin-like receptors)—CXCL2—dilated cardiomyopathy	0.00502	0.00543	CbGpPWpGaD
Pasireotide—SSTR3—Class A/1 (Rhodopsin-like receptors)—AGTR2—dilated cardiomyopathy	0.00502	0.00543	CbGpPWpGaD
Pasireotide—SSTR5—G alpha (i) signalling events—CXCR3—dilated cardiomyopathy	0.00499	0.0054	CbGpPWpGaD
Pasireotide—SSTR5—GPCRs, Class A Rhodopsin-like—AGTR2—dilated cardiomyopathy	0.00498	0.00539	CbGpPWpGaD
Pasireotide—SSTR2—G alpha (i) signalling events—CXCL2—dilated cardiomyopathy	0.00496	0.00536	CbGpPWpGaD
Pasireotide—SSTR2—G alpha (i) signalling events—AGTR2—dilated cardiomyopathy	0.00496	0.00536	CbGpPWpGaD
Pasireotide—SSTR5—Peptide ligand-binding receptors—AGTR1—dilated cardiomyopathy	0.0049	0.0053	CbGpPWpGaD
Pasireotide—SSTR1—Class A/1 (Rhodopsin-like receptors)—CXCL2—dilated cardiomyopathy	0.00481	0.00521	CbGpPWpGaD
Pasireotide—SSTR1—Class A/1 (Rhodopsin-like receptors)—AGTR2—dilated cardiomyopathy	0.00481	0.00521	CbGpPWpGaD
Pasireotide—SSTR3—Class A/1 (Rhodopsin-like receptors)—CXCR3—dilated cardiomyopathy	0.00467	0.00505	CbGpPWpGaD
Pasireotide—SSTR5—GPCRs, Class A Rhodopsin-like—CXCR3—dilated cardiomyopathy	0.00463	0.00501	CbGpPWpGaD
Pasireotide—SSTR2—G alpha (i) signalling events—CXCR3—dilated cardiomyopathy	0.00461	0.00499	CbGpPWpGaD
Pasireotide—SSTR2—GPCRs, Class A Rhodopsin-like—AGTR2—dilated cardiomyopathy	0.0046	0.00498	CbGpPWpGaD
Pasireotide—SSTR3—Class A/1 (Rhodopsin-like receptors)—ADRB1—dilated cardiomyopathy	0.00452	0.00489	CbGpPWpGaD
Pasireotide—SSTR2—Peptide ligand-binding receptors—AGTR1—dilated cardiomyopathy	0.00452	0.00489	CbGpPWpGaD
Pasireotide—SSTR3—GPCRs, Class A Rhodopsin-like—AGTR1—dilated cardiomyopathy	0.00451	0.00488	CbGpPWpGaD
Pasireotide—SSTR5—GPCRs, Class A Rhodopsin-like—ADRB1—dilated cardiomyopathy	0.00449	0.00486	CbGpPWpGaD
Pasireotide—SSTR1—Class A/1 (Rhodopsin-like receptors)—CXCR3—dilated cardiomyopathy	0.00448	0.00484	CbGpPWpGaD
Pasireotide—SSTR2—SIDS Susceptibility Pathways—IL10—dilated cardiomyopathy	0.00443	0.0048	CbGpPWpGaD
Pasireotide—SSTR1—Class A/1 (Rhodopsin-like receptors)—ADRB1—dilated cardiomyopathy	0.00434	0.00469	CbGpPWpGaD
Pasireotide—SSTR1—GPCRs, Class A Rhodopsin-like—AGTR1—dilated cardiomyopathy	0.00432	0.00468	CbGpPWpGaD
Pasireotide—SSTR3—GPCRs, Class A Rhodopsin-like—ADRB2—dilated cardiomyopathy	0.00428	0.00463	CbGpPWpGaD
Pasireotide—SSTR2—GPCRs, Class A Rhodopsin-like—CXCR3—dilated cardiomyopathy	0.00428	0.00463	CbGpPWpGaD
Pasireotide—SSTR5—Class A/1 (Rhodopsin-like receptors)—CXCL2—dilated cardiomyopathy	0.00427	0.00462	CbGpPWpGaD
Pasireotide—SSTR5—Class A/1 (Rhodopsin-like receptors)—AGTR2—dilated cardiomyopathy	0.00427	0.00462	CbGpPWpGaD
Pasireotide—SSTR2—GPCRs, Class A Rhodopsin-like—ADRB1—dilated cardiomyopathy	0.00414	0.00448	CbGpPWpGaD
Pasireotide—SSTR1—GPCRs, Class A Rhodopsin-like—ADRB2—dilated cardiomyopathy	0.0041	0.00444	CbGpPWpGaD
Pasireotide—SSTR3—Peptide ligand-binding receptors—AGT—dilated cardiomyopathy	0.00405	0.00438	CbGpPWpGaD
Pasireotide—SSTR5—Class A/1 (Rhodopsin-like receptors)—CXCR3—dilated cardiomyopathy	0.00397	0.0043	CbGpPWpGaD
Pasireotide—SSTR2—Class A/1 (Rhodopsin-like receptors)—CXCL2—dilated cardiomyopathy	0.00394	0.00426	CbGpPWpGaD
Pasireotide—SSTR2—Class A/1 (Rhodopsin-like receptors)—AGTR2—dilated cardiomyopathy	0.00394	0.00426	CbGpPWpGaD
Pasireotide—SSTR1—Peptide ligand-binding receptors—AGT—dilated cardiomyopathy	0.00388	0.0042	CbGpPWpGaD
Pasireotide—SSTR3—Class A/1 (Rhodopsin-like receptors)—AGTR1—dilated cardiomyopathy	0.00386	0.00418	CbGpPWpGaD
Pasireotide—SSTR5—Class A/1 (Rhodopsin-like receptors)—ADRB1—dilated cardiomyopathy	0.00384	0.00416	CbGpPWpGaD
Pasireotide—SSTR5—GPCRs, Class A Rhodopsin-like—AGTR1—dilated cardiomyopathy	0.00383	0.00415	CbGpPWpGaD
Pasireotide—SSTR3—GPCR ligand binding—AGTR2—dilated cardiomyopathy	0.00382	0.00414	CbGpPWpGaD
Pasireotide—SSTR3—GPCR ligand binding—CXCL2—dilated cardiomyopathy	0.00382	0.00414	CbGpPWpGaD
Pasireotide—SSTR1—Class A/1 (Rhodopsin-like receptors)—AGTR1—dilated cardiomyopathy	0.0037	0.00401	CbGpPWpGaD
Pasireotide—SSTR1—GPCR ligand binding—CXCL2—dilated cardiomyopathy	0.00367	0.00397	CbGpPWpGaD
Pasireotide—SSTR1—GPCR ligand binding—AGTR2—dilated cardiomyopathy	0.00367	0.00397	CbGpPWpGaD
Pasireotide—SSTR2—Class A/1 (Rhodopsin-like receptors)—CXCR3—dilated cardiomyopathy	0.00366	0.00396	CbGpPWpGaD
Pasireotide—SSTR3—Class A/1 (Rhodopsin-like receptors)—ADRB2—dilated cardiomyopathy	0.00366	0.00396	CbGpPWpGaD
Pasireotide—SSTR5—GPCRs, Class A Rhodopsin-like—ADRB2—dilated cardiomyopathy	0.00364	0.00393	CbGpPWpGaD
Pasireotide—SSTR3—GPCR ligand binding—CXCR3—dilated cardiomyopathy	0.00356	0.00385	CbGpPWpGaD
Pasireotide—SSTR2—Class A/1 (Rhodopsin-like receptors)—ADRB1—dilated cardiomyopathy	0.00355	0.00384	CbGpPWpGaD
Pasireotide—SSTR2—GPCRs, Class A Rhodopsin-like—AGTR1—dilated cardiomyopathy	0.00354	0.00383	CbGpPWpGaD
Pasireotide—SSTR1—Class A/1 (Rhodopsin-like receptors)—ADRB2—dilated cardiomyopathy	0.00351	0.0038	CbGpPWpGaD
Pasireotide—SSTR5—Peptide ligand-binding receptors—AGT—dilated cardiomyopathy	0.00344	0.00373	CbGpPWpGaD
Pasireotide—SSTR3—GPCR ligand binding—ADRB1—dilated cardiomyopathy	0.00344	0.00373	CbGpPWpGaD
Pasireotide—SSTR3—G alpha (i) signalling events—AGT—dilated cardiomyopathy	0.00342	0.0037	CbGpPWpGaD
Pasireotide—SSTR1—GPCR ligand binding—CXCR3—dilated cardiomyopathy	0.00341	0.00369	CbGpPWpGaD
Pasireotide—SSTR2—GPCRs, Class A Rhodopsin-like—ADRB2—dilated cardiomyopathy	0.00336	0.00363	CbGpPWpGaD
Pasireotide—Diabetes mellitus—Furosemide—dilated cardiomyopathy	0.00333	0.0439	CcSEcCtD
Pasireotide—SSTR1—GPCR ligand binding—ADRB1—dilated cardiomyopathy	0.0033	0.00357	CbGpPWpGaD
Pasireotide—SSTR5—Class A/1 (Rhodopsin-like receptors)—AGTR1—dilated cardiomyopathy	0.00328	0.00355	CbGpPWpGaD
Pasireotide—SSTR1—G alpha (i) signalling events—AGT—dilated cardiomyopathy	0.00328	0.00355	CbGpPWpGaD
Pasireotide—SSTR5—GPCR ligand binding—CXCL2—dilated cardiomyopathy	0.00325	0.00352	CbGpPWpGaD
Pasireotide—SSTR5—GPCR ligand binding—AGTR2—dilated cardiomyopathy	0.00325	0.00352	CbGpPWpGaD
Pasireotide—Alopecia—Spironolactone—dilated cardiomyopathy	0.00325	0.0429	CcSEcCtD
Pasireotide—SSTR2—Peptide ligand-binding receptors—AGT—dilated cardiomyopathy	0.00318	0.00344	CbGpPWpGaD
Pasireotide—SSTR5—Class A/1 (Rhodopsin-like receptors)—ADRB2—dilated cardiomyopathy	0.00312	0.00337	CbGpPWpGaD
Pasireotide—SSTR2—Class A/1 (Rhodopsin-like receptors)—AGTR1—dilated cardiomyopathy	0.00303	0.00328	CbGpPWpGaD
Pasireotide—SSTR5—GPCR ligand binding—CXCR3—dilated cardiomyopathy	0.00302	0.00327	CbGpPWpGaD
Pasireotide—SSTR2—GPCR ligand binding—AGTR2—dilated cardiomyopathy	0.003	0.00325	CbGpPWpGaD
Pasireotide—SSTR2—GPCR ligand binding—CXCL2—dilated cardiomyopathy	0.003	0.00325	CbGpPWpGaD
Pasireotide—SSTR3—GPCR ligand binding—AGTR1—dilated cardiomyopathy	0.00294	0.00318	CbGpPWpGaD
Pasireotide—SSTR5—GPCR ligand binding—ADRB1—dilated cardiomyopathy	0.00293	0.00317	CbGpPWpGaD
Pasireotide—SSTR5—G alpha (i) signalling events—AGT—dilated cardiomyopathy	0.00291	0.00314	CbGpPWpGaD
Pasireotide—SSTR2—Class A/1 (Rhodopsin-like receptors)—ADRB2—dilated cardiomyopathy	0.00287	0.00311	CbGpPWpGaD
Pasireotide—SSTR1—GPCR ligand binding—AGTR1—dilated cardiomyopathy	0.00282	0.00305	CbGpPWpGaD
Pasireotide—SSTR3—GPCR ligand binding—ADRB2—dilated cardiomyopathy	0.00279	0.00302	CbGpPWpGaD
Pasireotide—SSTR2—GPCR ligand binding—CXCR3—dilated cardiomyopathy	0.00279	0.00302	CbGpPWpGaD
Pasireotide—SSTR3—Class A/1 (Rhodopsin-like receptors)—AGT—dilated cardiomyopathy	0.00272	0.00294	CbGpPWpGaD
Pasireotide—SSTR2—GPCR ligand binding—ADRB1—dilated cardiomyopathy	0.0027	0.00292	CbGpPWpGaD
Pasireotide—SSTR2—G alpha (i) signalling events—AGT—dilated cardiomyopathy	0.00268	0.0029	CbGpPWpGaD
Pasireotide—SSTR1—GPCR ligand binding—ADRB2—dilated cardiomyopathy	0.00267	0.00289	CbGpPWpGaD
Pasireotide—Hypokalaemia—Furosemide—dilated cardiomyopathy	0.00263	0.0347	CcSEcCtD
Pasireotide—SSTR1—Class A/1 (Rhodopsin-like receptors)—AGT—dilated cardiomyopathy	0.00261	0.00282	CbGpPWpGaD
Pasireotide—Abdominal distension—Furosemide—dilated cardiomyopathy	0.00252	0.0332	CcSEcCtD
Pasireotide—SSTR5—GPCR ligand binding—AGTR1—dilated cardiomyopathy	0.0025	0.00271	CbGpPWpGaD
Pasireotide—Diabetes mellitus—Lisinopril—dilated cardiomyopathy	0.0025	0.0329	CcSEcCtD
Pasireotide—SSTR5—GPCR ligand binding—ADRB2—dilated cardiomyopathy	0.00237	0.00257	CbGpPWpGaD
Pasireotide—SSTR5—Class A/1 (Rhodopsin-like receptors)—AGT—dilated cardiomyopathy	0.00231	0.0025	CbGpPWpGaD
Pasireotide—SSTR2—GPCR ligand binding—AGTR1—dilated cardiomyopathy	0.00231	0.0025	CbGpPWpGaD
Pasireotide—Hyperglycaemia—Furosemide—dilated cardiomyopathy	0.00226	0.0298	CcSEcCtD
Pasireotide—Hypoglycaemia—Lisinopril—dilated cardiomyopathy	0.00222	0.0294	CcSEcCtD
Pasireotide—SSTR2—GPCR ligand binding—ADRB2—dilated cardiomyopathy	0.00219	0.00237	CbGpPWpGaD
Pasireotide—Pain in extremity—Lisinopril—dilated cardiomyopathy	0.00217	0.0286	CcSEcCtD
Pasireotide—SSTR3—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	0.00216	0.00234	CbGpPWpGaD
Pasireotide—SSTR3—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	0.00216	0.00234	CbGpPWpGaD
Pasireotide—SSTR2—Class A/1 (Rhodopsin-like receptors)—AGT—dilated cardiomyopathy	0.00213	0.00231	CbGpPWpGaD
Pasireotide—SSTR1—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	0.00207	0.00224	CbGpPWpGaD
Pasireotide—SSTR1—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	0.00207	0.00224	CbGpPWpGaD
Pasireotide—SSTR3—GPCR ligand binding—AGT—dilated cardiomyopathy	0.00207	0.00224	CbGpPWpGaD
Pasireotide—SSTR1—SIDS Susceptibility Pathways—TNF—dilated cardiomyopathy	0.00206	0.00223	CbGpPWpGaD
Pasireotide—SSTR3—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	0.00201	0.00217	CbGpPWpGaD
Pasireotide—SSTR1—GPCR ligand binding—AGT—dilated cardiomyopathy	0.00198	0.00215	CbGpPWpGaD
Pasireotide—SSTR3—Signaling by GPCR—CXCL2—dilated cardiomyopathy	0.00196	0.00212	CbGpPWpGaD
Pasireotide—SSTR3—Signaling by GPCR—AGTR2—dilated cardiomyopathy	0.00196	0.00212	CbGpPWpGaD
Pasireotide—SSTR3—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	0.00195	0.00211	CbGpPWpGaD
Pasireotide—Nasopharyngitis—Lisinopril—dilated cardiomyopathy	0.00194	0.0256	CcSEcCtD
Pasireotide—SSTR1—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	0.00193	0.00208	CbGpPWpGaD
Pasireotide—SSTR1—Signaling by GPCR—AGTR2—dilated cardiomyopathy	0.00188	0.00204	CbGpPWpGaD
Pasireotide—SSTR1—Signaling by GPCR—CXCL2—dilated cardiomyopathy	0.00188	0.00204	CbGpPWpGaD
Pasireotide—Influenza—Lisinopril—dilated cardiomyopathy	0.00188	0.0248	CcSEcCtD
Pasireotide—SSTR1—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	0.00187	0.00202	CbGpPWpGaD
Pasireotide—Pruritus—Spironolactone—dilated cardiomyopathy	0.00185	0.0244	CcSEcCtD
Pasireotide—SSTR5—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	0.00184	0.00199	CbGpPWpGaD
Pasireotide—SSTR5—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	0.00184	0.00199	CbGpPWpGaD
Pasireotide—SSTR3—Signaling by GPCR—CXCR3—dilated cardiomyopathy	0.00182	0.00197	CbGpPWpGaD
Pasireotide—Diarrhoea—Spironolactone—dilated cardiomyopathy	0.00179	0.0236	CcSEcCtD
Pasireotide—SSTR3—Signaling by GPCR—ADRB1—dilated cardiomyopathy	0.00177	0.00191	CbGpPWpGaD
Pasireotide—SSTR5—GPCR ligand binding—AGT—dilated cardiomyopathy	0.00176	0.0019	CbGpPWpGaD
Pasireotide—SSTR1—Signaling by GPCR—CXCR3—dilated cardiomyopathy	0.00175	0.00189	CbGpPWpGaD
Pasireotide—Dizziness—Spironolactone—dilated cardiomyopathy	0.00173	0.0228	CcSEcCtD
Pasireotide—SSTR5—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	0.00171	0.00185	CbGpPWpGaD
Pasireotide—SSTR2—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	0.0017	0.00184	CbGpPWpGaD
Pasireotide—SSTR2—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	0.0017	0.00184	CbGpPWpGaD
Pasireotide—SSTR1—Signaling by GPCR—ADRB1—dilated cardiomyopathy	0.00169	0.00183	CbGpPWpGaD
Pasireotide—Hyperglycaemia—Lisinopril—dilated cardiomyopathy	0.00169	0.0223	CcSEcCtD
Pasireotide—SSTR2—SIDS Susceptibility Pathways—TNF—dilated cardiomyopathy	0.00169	0.00183	CbGpPWpGaD
Pasireotide—SSTR5—Signaling by GPCR—CXCL2—dilated cardiomyopathy	0.00167	0.00181	CbGpPWpGaD
Pasireotide—SSTR5—Signaling by GPCR—AGTR2—dilated cardiomyopathy	0.00167	0.00181	CbGpPWpGaD
Pasireotide—Vomiting—Spironolactone—dilated cardiomyopathy	0.00166	0.0219	CcSEcCtD
Pasireotide—SSTR3—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	0.00166	0.0018	CbGpPWpGaD
Pasireotide—SSTR5—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	0.00165	0.00179	CbGpPWpGaD
Pasireotide—Headache—Spironolactone—dilated cardiomyopathy	0.00164	0.0216	CcSEcCtD
Pasireotide—SSTR2—GPCR ligand binding—AGT—dilated cardiomyopathy	0.00162	0.00176	CbGpPWpGaD
Pasireotide—Anaemia—Furosemide—dilated cardiomyopathy	0.00161	0.0213	CcSEcCtD
Pasireotide—SSTR1—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	0.00159	0.00172	CbGpPWpGaD
Pasireotide—SSTR2—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	0.00158	0.00171	CbGpPWpGaD
Pasireotide—SSTR3—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	0.00158	0.00171	CbGpPWpGaD
Pasireotide—Vertigo—Furosemide—dilated cardiomyopathy	0.00157	0.0207	CcSEcCtD
Pasireotide—Nausea—Spironolactone—dilated cardiomyopathy	0.00155	0.0205	CcSEcCtD
Pasireotide—SSTR5—Signaling by GPCR—CXCR3—dilated cardiomyopathy	0.00155	0.00168	CbGpPWpGaD
Pasireotide—SSTR2—Signaling by GPCR—AGTR2—dilated cardiomyopathy	0.00154	0.00167	CbGpPWpGaD
Pasireotide—SSTR2—Signaling by GPCR—CXCL2—dilated cardiomyopathy	0.00154	0.00167	CbGpPWpGaD
Pasireotide—SSTR2—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	0.00153	0.00165	CbGpPWpGaD
Pasireotide—SSTR1—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	0.00151	0.00164	CbGpPWpGaD
Pasireotide—SSTR3—Signaling by GPCR—AGTR1—dilated cardiomyopathy	0.00151	0.00163	CbGpPWpGaD
Pasireotide—SSTR5—Signaling by GPCR—ADRB1—dilated cardiomyopathy	0.0015	0.00163	CbGpPWpGaD
Pasireotide—Oedema peripheral—Lisinopril—dilated cardiomyopathy	0.00148	0.0195	CcSEcCtD
Pasireotide—SSTR1—Signaling by GPCR—AGTR1—dilated cardiomyopathy	0.00145	0.00157	CbGpPWpGaD
Pasireotide—SSTR3—Signaling by GPCR—ADRB2—dilated cardiomyopathy	0.00143	0.00155	CbGpPWpGaD
Pasireotide—SSTR2—Signaling by GPCR—CXCR3—dilated cardiomyopathy	0.00143	0.00155	CbGpPWpGaD
Pasireotide—SSTR5—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	0.00141	0.00153	CbGpPWpGaD
Pasireotide—SSTR2—Signaling by GPCR—ADRB1—dilated cardiomyopathy	0.00139	0.0015	CbGpPWpGaD
Pasireotide—SSTR1—Signaling by GPCR—ADRB2—dilated cardiomyopathy	0.00137	0.00149	CbGpPWpGaD
Pasireotide—SSTR5—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	0.00134	0.00145	CbGpPWpGaD
Pasireotide—Hypotension—Furosemide—dilated cardiomyopathy	0.00133	0.0175	CcSEcCtD
Pasireotide—Alopecia—Lisinopril—dilated cardiomyopathy	0.00133	0.0175	CcSEcCtD
Pasireotide—SSTR3—Signaling Pathways—PSEN2—dilated cardiomyopathy	0.00131	0.00141	CbGpPWpGaD
Pasireotide—SSTR2—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	0.0013	0.00141	CbGpPWpGaD
Pasireotide—SSTR5—Signaling by GPCR—AGTR1—dilated cardiomyopathy	0.00128	0.00139	CbGpPWpGaD
Pasireotide—Back pain—Lisinopril—dilated cardiomyopathy	0.00126	0.0167	CcSEcCtD
Pasireotide—SSTR1—Signaling Pathways—PSEN2—dilated cardiomyopathy	0.00125	0.00135	CbGpPWpGaD
Pasireotide—SSTR2—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	0.00124	0.00134	CbGpPWpGaD
Pasireotide—Decreased appetite—Furosemide—dilated cardiomyopathy	0.00124	0.0163	CcSEcCtD
Pasireotide—Fatigue—Furosemide—dilated cardiomyopathy	0.00123	0.0162	CcSEcCtD
Pasireotide—SSTR3—GPCR downstream signaling—RAC1—dilated cardiomyopathy	0.00122	0.00132	CbGpPWpGaD
Pasireotide—SSTR5—Signaling by GPCR—ADRB2—dilated cardiomyopathy	0.00122	0.00132	CbGpPWpGaD
Pasireotide—Constipation—Furosemide—dilated cardiomyopathy	0.00122	0.016	CcSEcCtD
Pasireotide—Anaemia—Lisinopril—dilated cardiomyopathy	0.00121	0.0159	CcSEcCtD
Pasireotide—SSTR2—Signaling by GPCR—AGTR1—dilated cardiomyopathy	0.00118	0.00128	CbGpPWpGaD
Pasireotide—Vertigo—Lisinopril—dilated cardiomyopathy	0.00117	0.0155	CcSEcCtD
Pasireotide—SSTR1—GPCR downstream signaling—RAC1—dilated cardiomyopathy	0.00117	0.00127	CbGpPWpGaD
Pasireotide—SSTR3—GPCR downstream signaling—AGT—dilated cardiomyopathy	0.00117	0.00127	CbGpPWpGaD
Pasireotide—Gastrointestinal pain—Furosemide—dilated cardiomyopathy	0.00116	0.0153	CcSEcCtD
Pasireotide—SSTR3—Signaling Pathways—AGTR2—dilated cardiomyopathy	0.00116	0.00125	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—CXCL2—dilated cardiomyopathy	0.00116	0.00125	CbGpPWpGaD
Pasireotide—Abdominal pain—Furosemide—dilated cardiomyopathy	0.00112	0.0148	CcSEcCtD
Pasireotide—SSTR2—Signaling by GPCR—ADRB2—dilated cardiomyopathy	0.00112	0.00122	CbGpPWpGaD
Pasireotide—SSTR1—GPCR downstream signaling—AGT—dilated cardiomyopathy	0.00112	0.00121	CbGpPWpGaD
Pasireotide—Arthralgia—Lisinopril—dilated cardiomyopathy	0.00111	0.0147	CcSEcCtD
Pasireotide—Myalgia—Lisinopril—dilated cardiomyopathy	0.00111	0.0147	CcSEcCtD
Pasireotide—SSTR1—Signaling Pathways—CXCL2—dilated cardiomyopathy	0.00111	0.0012	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—AGTR2—dilated cardiomyopathy	0.00111	0.0012	CbGpPWpGaD
Pasireotide—SSTR3—Signaling by GPCR—RAC1—dilated cardiomyopathy	0.00111	0.0012	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—PSEN2—dilated cardiomyopathy	0.00111	0.0012	CbGpPWpGaD
Pasireotide—Anxiety—Lisinopril—dilated cardiomyopathy	0.00111	0.0146	CcSEcCtD
Pasireotide—SSTR3—Signaling Pathways—CXCR3—dilated cardiomyopathy	0.00108	0.00117	CbGpPWpGaD
Pasireotide—SSTR1—Signaling by GPCR—RAC1—dilated cardiomyopathy	0.00107	0.00115	CbGpPWpGaD
Pasireotide—SSTR3—Signaling by GPCR—AGT—dilated cardiomyopathy	0.00106	0.00115	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—ADRB1—dilated cardiomyopathy	0.00104	0.00113	CbGpPWpGaD
Pasireotide—SSTR5—GPCR downstream signaling—RAC1—dilated cardiomyopathy	0.00104	0.00113	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—CXCR3—dilated cardiomyopathy	0.00103	0.00112	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—PSEN2—dilated cardiomyopathy	0.00102	0.00111	CbGpPWpGaD
Pasireotide—Asthenia—Furosemide—dilated cardiomyopathy	0.00102	0.0135	CcSEcCtD
Pasireotide—SSTR1—Signaling by GPCR—AGT—dilated cardiomyopathy	0.00102	0.0011	CbGpPWpGaD
Pasireotide—Pruritus—Furosemide—dilated cardiomyopathy	0.00101	0.0133	CcSEcCtD
Pasireotide—SSTR1—Signaling Pathways—ADRB1—dilated cardiomyopathy	0.001	0.00108	CbGpPWpGaD
Pasireotide—Hypotension—Lisinopril—dilated cardiomyopathy	0.000997	0.0132	CcSEcCtD
Pasireotide—SSTR5—GPCR downstream signaling—AGT—dilated cardiomyopathy	0.000994	0.00108	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—CXCL2—dilated cardiomyopathy	0.000986	0.00107	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—AGTR2—dilated cardiomyopathy	0.000986	0.00107	CbGpPWpGaD
Pasireotide—Diarrhoea—Furosemide—dilated cardiomyopathy	0.000973	0.0128	CcSEcCtD
Pasireotide—Musculoskeletal discomfort—Lisinopril—dilated cardiomyopathy	0.000972	0.0128	CcSEcCtD
Pasireotide—Insomnia—Lisinopril—dilated cardiomyopathy	0.000965	0.0127	CcSEcCtD
Pasireotide—SSTR2—GPCR downstream signaling—RAC1—dilated cardiomyopathy	0.00096	0.00104	CbGpPWpGaD
Pasireotide—SSTR5—Signaling by GPCR—RAC1—dilated cardiomyopathy	0.000945	0.00102	CbGpPWpGaD
Pasireotide—Dizziness—Furosemide—dilated cardiomyopathy	0.00094	0.0124	CcSEcCtD
Pasireotide—Decreased appetite—Lisinopril—dilated cardiomyopathy	0.000928	0.0122	CcSEcCtD
Pasireotide—Fatigue—Lisinopril—dilated cardiomyopathy	0.00092	0.0121	CcSEcCtD
Pasireotide—SSTR2—GPCR downstream signaling—AGT—dilated cardiomyopathy	0.000918	0.000993	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—CXCR3—dilated cardiomyopathy	0.000916	0.000992	CbGpPWpGaD
Pasireotide—Constipation—Lisinopril—dilated cardiomyopathy	0.000912	0.012	CcSEcCtD
Pasireotide—SSTR2—Signaling Pathways—AGTR2—dilated cardiomyopathy	0.00091	0.000984	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—CXCL2—dilated cardiomyopathy	0.00091	0.000984	CbGpPWpGaD
Pasireotide—Vomiting—Furosemide—dilated cardiomyopathy	0.000904	0.0119	CcSEcCtD
Pasireotide—SSTR5—Signaling by GPCR—AGT—dilated cardiomyopathy	0.000903	0.000977	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—AGTR1—dilated cardiomyopathy	0.000892	0.000965	CbGpPWpGaD
Pasireotide—Headache—Furosemide—dilated cardiomyopathy	0.000891	0.0118	CcSEcCtD
Pasireotide—SSTR5—Signaling Pathways—ADRB1—dilated cardiomyopathy	0.000888	0.00096	CbGpPWpGaD
Pasireotide—Gastrointestinal pain—Lisinopril—dilated cardiomyopathy	0.000873	0.0115	CcSEcCtD
Pasireotide—SSTR2—Signaling by GPCR—RAC1—dilated cardiomyopathy	0.000872	0.000944	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—AGTR1—dilated cardiomyopathy	0.000855	0.000925	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—CXCR3—dilated cardiomyopathy	0.000846	0.000915	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—ADRB2—dilated cardiomyopathy	0.000846	0.000915	CbGpPWpGaD
Pasireotide—Nausea—Furosemide—dilated cardiomyopathy	0.000845	0.0111	CcSEcCtD
Pasireotide—Abdominal pain—Lisinopril—dilated cardiomyopathy	0.000844	0.0111	CcSEcCtD
Pasireotide—SSTR2—Signaling by GPCR—AGT—dilated cardiomyopathy	0.000833	0.000902	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—ADRB1—dilated cardiomyopathy	0.000819	0.000886	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—ADRB2—dilated cardiomyopathy	0.000811	0.000877	CbGpPWpGaD
Pasireotide—Asthenia—Lisinopril—dilated cardiomyopathy	0.000766	0.0101	CcSEcCtD
Pasireotide—SSTR5—Signaling Pathways—AGTR1—dilated cardiomyopathy	0.000758	0.00082	CbGpPWpGaD
Pasireotide—Pruritus—Lisinopril—dilated cardiomyopathy	0.000755	0.00996	CcSEcCtD
Pasireotide—SSTR3—Signaling by GPCR—RAF1—dilated cardiomyopathy	0.000737	0.000797	CbGpPWpGaD
Pasireotide—Diarrhoea—Lisinopril—dilated cardiomyopathy	0.00073	0.00963	CcSEcCtD
Pasireotide—SSTR3—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	0.000727	0.000786	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—ADRB2—dilated cardiomyopathy	0.000719	0.000778	CbGpPWpGaD
Pasireotide—SSTR1—Signaling by GPCR—RAF1—dilated cardiomyopathy	0.000707	0.000765	CbGpPWpGaD
Pasireotide—Dizziness—Lisinopril—dilated cardiomyopathy	0.000706	0.00931	CcSEcCtD
Pasireotide—SSTR2—Signaling Pathways—AGTR1—dilated cardiomyopathy	0.0007	0.000757	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	0.000697	0.000754	CbGpPWpGaD
Pasireotide—Vomiting—Lisinopril—dilated cardiomyopathy	0.000678	0.00895	CcSEcCtD
Pasireotide—Headache—Lisinopril—dilated cardiomyopathy	0.000668	0.00882	CcSEcCtD
Pasireotide—SSTR2—Signaling Pathways—ADRB2—dilated cardiomyopathy	0.000664	0.000718	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—RAC1—dilated cardiomyopathy	0.000657	0.00071	CbGpPWpGaD
Pasireotide—Nausea—Lisinopril—dilated cardiomyopathy	0.000634	0.00836	CcSEcCtD
Pasireotide—SSTR1—Signaling Pathways—RAC1—dilated cardiomyopathy	0.00063	0.000681	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—AGT—dilated cardiomyopathy	0.000627	0.000679	CbGpPWpGaD
Pasireotide—SSTR5—Signaling by GPCR—RAF1—dilated cardiomyopathy	0.000627	0.000678	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	0.000618	0.000669	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—AGT—dilated cardiomyopathy	0.000601	0.000651	CbGpPWpGaD
Pasireotide—SSTR2—Signaling by GPCR—RAF1—dilated cardiomyopathy	0.000578	0.000626	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	0.00057	0.000617	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—RAC1—dilated cardiomyopathy	0.000558	0.000604	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—AGT—dilated cardiomyopathy	0.000533	0.000577	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—RAC1—dilated cardiomyopathy	0.000515	0.000557	CbGpPWpGaD
Pasireotide—SSTR3—Signaling by GPCR—EGFR—dilated cardiomyopathy	0.000505	0.000547	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—AGT—dilated cardiomyopathy	0.000492	0.000533	CbGpPWpGaD
Pasireotide—SSTR1—Signaling by GPCR—EGFR—dilated cardiomyopathy	0.000485	0.000524	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—RAF1—dilated cardiomyopathy	0.000435	0.000471	CbGpPWpGaD
Pasireotide—SSTR5—Signaling by GPCR—EGFR—dilated cardiomyopathy	0.00043	0.000465	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—RAF1—dilated cardiomyopathy	0.000417	0.000452	CbGpPWpGaD
Pasireotide—SSTR2—Signaling by GPCR—EGFR—dilated cardiomyopathy	0.000397	0.000429	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—RAF1—dilated cardiomyopathy	0.00037	0.000401	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—RAF1—dilated cardiomyopathy	0.000342	0.00037	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—EGFR—dilated cardiomyopathy	0.000299	0.000323	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—EGFR—dilated cardiomyopathy	0.000286	0.00031	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—EGFR—dilated cardiomyopathy	0.000254	0.000275	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—EGFR—dilated cardiomyopathy	0.000234	0.000253	CbGpPWpGaD
